Siegfried Kasper

54.7k total citations · 3 hit papers
1.0k papers, 34.8k citations indexed

About

Siegfried Kasper is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, Siegfried Kasper has authored 1.0k papers receiving a total of 34.8k indexed citations (citations by other indexed papers that have themselves been cited), including 341 papers in Psychiatry and Mental health, 320 papers in Pharmacology and 176 papers in Experimental and Cognitive Psychology. Recurrent topics in Siegfried Kasper's work include Treatment of Major Depression (300 papers), Bipolar Disorder and Treatment (152 papers) and Tryptophan and brain disorders (140 papers). Siegfried Kasper is often cited by papers focused on Treatment of Major Depression (300 papers), Bipolar Disorder and Treatment (152 papers) and Tryptophan and brain disorders (140 papers). Siegfried Kasper collaborates with scholars based in Austria, Germany and United States. Siegfried Kasper's co-authors include Rupert Lanzenberger, Stuart Montgomery, Hans‐Jürgen Möller, Dietmar Winkler, N. Praschak-Rieder, Matthäus Willeit, Joseph Zohar, Alexander Neumeister, Heinz Grunze and Eduard Vieta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Biological Chemistry.

In The Last Decade

Siegfried Kasper

997 papers receiving 33.3k citations

Hit Papers

Epidemiological Findings ... 1989 2026 2001 2013 1989 2017 2019 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Siegfried Kasper 10.1k 8.0k 6.3k 5.6k 5.1k 1.0k 34.8k
Alessandro Serretti 9.0k 0.9× 5.8k 0.7× 5.3k 0.8× 3.2k 0.6× 4.3k 0.9× 738 26.4k
Sidney H. Kennedy 10.0k 1.0× 7.6k 0.9× 6.2k 1.0× 8.2k 1.5× 3.9k 0.8× 678 37.6k
Philip J. Cowen 5.2k 0.5× 6.6k 0.8× 6.5k 1.0× 7.9k 1.4× 8.3k 1.6× 608 29.2k
Alan F. Schatzberg 6.8k 0.7× 7.4k 0.9× 7.7k 1.2× 10.8k 1.9× 3.3k 0.7× 421 34.1k
Guy M. Goodwin 14.3k 1.4× 5.4k 0.7× 6.6k 1.0× 9.0k 1.6× 4.6k 0.9× 476 35.0k
Stephen R. Wisniewski 13.3k 1.3× 13.0k 1.6× 7.7k 1.2× 4.1k 0.7× 3.1k 0.6× 492 42.6k
David Nutt 4.7k 0.5× 4.8k 0.6× 5.2k 0.8× 6.0k 1.1× 11.1k 2.2× 701 33.7k
Robert M. Post 20.1k 2.0× 4.1k 0.5× 3.4k 0.5× 7.0k 1.3× 6.9k 1.4× 586 37.3k
Roger S. McIntyre 15.6k 1.6× 8.8k 1.1× 6.6k 1.0× 4.2k 0.7× 2.3k 0.5× 1.0k 46.1k
J. John Mann 10.4k 1.0× 6.6k 0.8× 4.3k 0.7× 6.6k 1.2× 9.6k 1.9× 640 47.3k

Countries citing papers authored by Siegfried Kasper

Since Specialization
Citations

This map shows the geographic impact of Siegfried Kasper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siegfried Kasper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siegfried Kasper more than expected).

Fields of papers citing papers by Siegfried Kasper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siegfried Kasper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siegfried Kasper. The network helps show where Siegfried Kasper may publish in the future.

Co-authorship network of co-authors of Siegfried Kasper

This figure shows the co-authorship network connecting the top 25 collaborators of Siegfried Kasper. A scholar is included among the top collaborators of Siegfried Kasper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siegfried Kasper. Siegfried Kasper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luca, Antonina, Maria Luca, Siegfried Kasper, et al.. (2025). Mild motor signs and depression: more than just medication side effects?. European Archives of Psychiatry and Clinical Neuroscience. 276(2). 451–457.
2.
Stange, Rainer, et al.. (2024). Die Rolle von Phytotherapie bei COVID-19-assoziierter Angst und Depression. Zeitschrift für Phytotherapie. 45(4). 148–156. 1 indexed citations
3.
Dold, Markus, Hans‐Jürgen Möller, Hans‐Peter Volz, et al.. (2024). Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials. European Psychiatry. 67(1). e23–e23. 3 indexed citations
4.
Kasper, Siegfried, Hans‐Peter Volz, Hans‐Jürgen Möller, et al.. (2024). Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial. European Archives of Psychiatry and Clinical Neuroscience. 275(6). 1693–1703. 2 indexed citations
5.
Unterholzner, Jakob, C. Philippe, Godber Mathis Godbersen, et al.. (2023). Effects of bilateral sequential theta-burst stimulation on 5-HT1A receptors in the dorsolateral prefrontal cortex in treatment-resistant depression: a proof-of-concept trial. Translational Psychiatry. 13(1). 33–33. 7 indexed citations
6.
Godbersen, Godber Mathis, Murray Bruce Reed, Jakob Unterholzner, et al.. (2023). Effects of bilateral sequential theta-burst stimulation on functional connectivity in treatment-resistant depression: First results. Journal of Affective Disorders. 324. 660–669. 14 indexed citations
7.
Kautzky, Alexander, Lucie Bartova, Gernot Fugger, et al.. (2023). Age as a moderating factor of treatment resistance in depression. European Psychiatry. 66(1). e35–e35. 4 indexed citations
8.
Schosser, Alexandra, Birgit Ludwig, Laura Carlberg, et al.. (2022). BDNF gene polymorphisms predicting treatment response to CBT-based rehabilitation of depression. European Neuropsychopharmacology. 58. 103–108. 4 indexed citations
9.
Friedrich, Michaela‐Elena, R. Grohmann, Ulrich Rabl, et al.. (2022). Incidence of Drug-Induced Delirium During Treatment With Antidepressants or Antipsychotics: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2016. The International Journal of Neuropsychopharmacology. 25(7). 556–566. 7 indexed citations
10.
Shiozawa, Pedro, et al.. (2022). Cariprazine for treating psychosis: an updated meta-analysis. International Journal of Psychiatry in Clinical Practice. 27(1). 107–109. 1 indexed citations
11.
Volz, Hans‐Peter, Lucie Bartova, João M. Bessa, et al.. (2022). Sick leave duration as a potential marker of functionality and disease severity in depression. International Journal of Psychiatry in Clinical Practice. 26(4). 406–416. 9 indexed citations
12.
Bartova, Lucie, Markus Dold, Hans‐Peter Volz, et al.. (2022). Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited. European Archives of Psychiatry and Clinical Neuroscience. 273(1). 51–63. 11 indexed citations
13.
Rischka, Lucas, Godber Mathis Godbersen, Verena Pichler, et al.. (2021). Reliability of task-specific neuronal activation assessed with functional PET, ASL and BOLD imaging. Journal of Cerebral Blood Flow & Metabolism. 41(11). 2986–2999. 18 indexed citations
14.
Kautzky, Alexander, Markus Dold, Lucie Bartova, et al.. (2020). Combining machine learning algorithms for prediction of antidepressant treatment response. Acta Psychiatrica Scandinavica. 143(1). 36–49. 33 indexed citations
15.
Giridhar, Premkumar Vummidi, et al.. (2019). Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity. Cancer Research. 79(6). 1124–1137. 37 indexed citations
16.
Kraus, Christoph, Thomas Vanicek, M. Stamenković, et al.. (2018). DiGeorge syndrome. Wiener klinische Wochenschrift. 130(7-8). 283–287. 10 indexed citations
17.
Baldinger, P., Gregory M. James, Marius Hienert, et al.. (2016). PS183. Effect of electroconvulsive therapy on monoamine oxidase A binding - a preliminary report. The International Journal of Neuropsychopharmacology. 19(Suppl_1). 66–66. 1 indexed citations
18.
Gu, Guangyu, Jialing Yuan, Marcia L. Wills, & Siegfried Kasper. (2007). Prostate Cancer Cells with Stem Cell Characteristics Reconstitute the Original Human Tumor In vivo. Cancer Research. 67(10). 4807–4815. 283 indexed citations
19.
Bagli, M., Richard Süverkrüp, G. Höflich, et al.. (1999). Pharmacokinetic-Pharmacodynamic Modeling of Tolerance to the Prolactin-Secreting Effect of Chlorprothixene after Different Modes of Drug Administration. Journal of Pharmacology and Experimental Therapeutics. 291(2). 547–554. 14 indexed citations
20.
Zhao, Guang-Quan, Siegfried Kasper, Marcia E. Newcomer, et al.. (1998). Molecular Cloning and Hormonal Regulation of a Murine Epididymal Retinoic Acid-Binding Protein Messenger Ribonucleic Acid. Endocrinology. 139(6). 2971–2981. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026